Free Trial

Best Stocks Under $2 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $2.00 (2 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Western Copper & Gold stock logo

1. Western Copper & Gold NYSE:WRN

$1.27 +0.03 (+2.42%)
As of 08/21/2025 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$254.70 million
P/E Ratio
-63.50
Consensus Rating
Buy
Consensus Price Target
$4.00 (+215.0% Upside)
Volume
192,312 shares
Average Volume
373,463 shares
Quince Therapeutics stock logo

2. Quince Therapeutics NASDAQ:QNCX

$1.61 -0.02 (-1.23%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$1.62 +0.01 (+0.62%)
As of 08/21/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$87.55 million
P/E Ratio
-1.48
Consensus Rating
Buy
Consensus Price Target
$8.14 (+405.8% Upside)
Volume
61,949 shares
Average Volume
207,791 shares
Immunic stock logo

3. Immunic NASDAQ:IMUX

$0.94 +0.02 (+2.71%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$0.94 -0.01 (-1.05%)
As of 08/21/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$90.76 million
P/E Ratio
-0.77
Consensus Rating
Buy
Consensus Price Target
$7.50 (+693.7% Upside)
Volume
838,164 shares
Average Volume
1.10 million shares
Denison Mine stock logo

4. Denison Mine NYSEAMERICAN:DNN

$1.95 +0.03 (+1.56%)
Closing price 08/21/2025 04:10 PM Eastern
Extended Trading
$1.96 +0.01 (+0.26%)
As of 08/21/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mine

Market Capitalization
$1.72 billion
P/E Ratio
-32.50
Consensus Rating
Buy
Consensus Price Target
$3.00 (+53.8% Upside)
Volume
31.93 million shares
Average Volume
62.21 million shares
Stardust Power stock logo

5. Stardust Power NASDAQ:SDST

$0.38 -0.01 (-1.41%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$0.39 +0.00 (+1.17%)
As of 08/21/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$23.71 million
P/E Ratio
-0.69
Consensus Rating
Buy
Consensus Price Target
$5.11 (+1,229.6% Upside)
Volume
609,578 shares
Average Volume
2.14 million shares
Ur Energy stock logo

6. Ur Energy NYSEAMERICAN:URG

$1.24 +0.06 (+5.08%)
Closing price 08/21/2025 04:10 PM Eastern
Extended Trading
$1.25 +0.01 (+0.40%)
As of 08/21/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$430.50 million
P/E Ratio
-7.29
Consensus Rating
Buy
Consensus Price Target
$2.48 (+99.6% Upside)
Volume
3.40 million shares
Average Volume
4.10 million shares
Mereo BioPharma Group stock logo

7. Mereo BioPharma Group NASDAQ:MREO

$1.65 +0.02 (+1.23%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$1.65 0.00 (0.00%)
As of 08/21/2025 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$259.17 million
P/E Ratio
-23.57
Consensus Rating
Buy
Consensus Price Target
$7.20 (+336.4% Upside)
Volume
512,499 shares
Average Volume
1.43 million shares
FibroBiologics stock logo

8. FibroBiologics NASDAQ:FBLG

$0.59 +0.02 (+3.32%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$0.60 +0.01 (+2.39%)
As of 08/21/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologics

Market Capitalization
$23.88 million
P/E Ratio
-1.64
Consensus Rating
Buy
Consensus Price Target
$13.00 (+2,107.5% Upside)
Volume
306,513 shares
Average Volume
481,156 shares
FiscalNote stock logo

9. FiscalNote NYSE:NOTE

$0.50 +0.01 (+1.92%)
Closing price 08/21/2025 03:59 PM Eastern
Extended Trading
$0.50 +0.00 (+0.20%)
As of 08/21/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FiscalNote Holdings, Inc operates as technology company North America, Europe, Australia, and Asia. It combines artificial intelligence technology, machine learning, and other technologies with analytics, workflow tools, and expert research. More about FiscalNote

Market Capitalization
$77.46 million
P/E Ratio
-1.56
Consensus Rating
Buy
Consensus Price Target
$2.44 (+388.5% Upside)
Volume
1.16 million shares
Average Volume
2.69 million shares
Biomea Fusion stock logo

10. Biomea Fusion NASDAQ:BMEA

$1.80 +0.02 (+0.84%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$1.80 0.00 (0.00%)
As of 08/21/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. More about Biomea Fusion

Market Capitalization
$105.93 million
P/E Ratio
-0.59
Consensus Rating
Buy
Consensus Price Target
$16.80 (+835.9% Upside)
Volume
222,474 shares
Average Volume
739,436 shares
Context Therapeutics stock logo

11. Context Therapeutics NASDAQ:CNTX

$0.88 -0.02 (-2.74%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$0.89 +0.01 (+1.14%)
As of 08/21/2025 07:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context Therapeutics

Market Capitalization
$81.16 million
P/E Ratio
-2.44
Consensus Rating
Buy
Consensus Price Target
$5.25 (+496.6% Upside)
Volume
63,048 shares
Average Volume
188,001 shares
Ovid Therapeutics stock logo

12. Ovid Therapeutics NASDAQ:OVID

$0.96 +0.01 (+0.74%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$0.92 -0.04 (-3.76%)
As of 08/21/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization
$67.55 million
P/E Ratio
-1.81
Consensus Rating
Buy
Consensus Price Target
$3.10 (+223.9% Upside)
Volume
813,124 shares
Average Volume
1.59 million shares
Reviva Pharmaceuticals stock logo

13. Reviva Pharmaceuticals NASDAQ:RVPH

$0.52 +0.00 (+0.15%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$0.52 0.00 (0.00%)
As of 08/21/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$24.92 million
P/E Ratio
-0.80
Consensus Rating
Buy
Consensus Price Target
$7.17 (+1,278.2% Upside)
Volume
1.49 million shares
Average Volume
2.79 million shares
Aclaris Therapeutics stock logo

14. Aclaris Therapeutics NASDAQ:ACRS

$1.75 -0.06 (-3.31%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$1.80 +0.04 (+2.57%)
As of 08/21/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris Therapeutics

Market Capitalization
$196.08 million
P/E Ratio
-1.28
Consensus Rating
Buy
Consensus Price Target
$8.71 (+398.0% Upside)
Volume
260,116 shares
Average Volume
1.50 million shares
Bitfarms stock logo

15. Bitfarms NASDAQ:BITF

$1.23 -0.03 (-2.38%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$1.22 -0.01 (-0.81%)
As of 08/21/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bitfarms Ltd. engages in the mining of cryptocurrency coins and tokens in Canada, the United States, Paraguay, and Argentina. More about Bitfarms

Market Capitalization
$702.51 million
P/E Ratio
-7.23
Consensus Rating
Buy
Consensus Price Target
$3.95 (+221.1% Upside)
Volume
13.59 million shares
Average Volume
28.19 million shares
Lucid Diagnostics stock logo

16. Lucid Diagnostics NASDAQ:LUCD

$1.05 +0.02 (+1.94%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$1.03 -0.02 (-1.43%)
As of 08/21/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid Diagnostics

Market Capitalization
$111.73 million
P/E Ratio
-0.88
Consensus Rating
Buy
Consensus Price Target
$3.55 (+238.1% Upside)
Volume
803,646 shares
Average Volume
734,941 shares
Adicet Bio stock logo

17. Adicet Bio NASDAQ:ACET

$0.68 +0.04 (+6.67%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$0.71 +0.02 (+3.56%)
As of 08/21/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Adicet Bio, Inc, a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. More about Adicet Bio

Market Capitalization
$53.28 million
P/E Ratio
-0.52
Consensus Rating
Buy
Consensus Price Target
$6.00 (+778.9% Upside)
Volume
1.23 million shares
Average Volume
641,503 shares
Cabaletta Bio stock logo

18. Cabaletta Bio NASDAQ:CABA

$1.60 +0.02 (+1.27%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$1.63 +0.03 (+1.81%)
As of 08/21/2025 06:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cabaletta Bio, Inc, a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. More about Cabaletta Bio

Market Capitalization
$144.51 million
P/E Ratio
-0.59
Consensus Rating
Buy
Consensus Price Target
$14.43 (+801.8% Upside)
Volume
554,309 shares
Average Volume
1.35 million shares
InflaRx stock logo

19. InflaRx NASDAQ:IFRX

$0.90 +0.01 (+0.57%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$0.87 -0.03 (-3.01%)
As of 08/21/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. More about InflaRx

Market Capitalization
$59.94 million
P/E Ratio
-1.12
Consensus Rating
Buy
Consensus Price Target
$6.60 (+635.0% Upside)
Volume
271,493 shares
Average Volume
215,496 shares
Acrivon Therapeutics stock logo

20. Acrivon Therapeutics NASDAQ:ACRV

$1.32 +0.02 (+1.54%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$1.32 0.00 (0.00%)
As of 08/21/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Acrivon Therapeutics, Inc, a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. More about Acrivon Therapeutics

Market Capitalization
$40.89 million
P/E Ratio
-0.59
Consensus Rating
Buy
Consensus Price Target
$17.57 (+1,231.2% Upside)
Volume
111,773 shares
Average Volume
238,163 shares
IceCure Medical stock logo

21. IceCure Medical NASDAQ:ICCM

$0.88 +0.02 (+2.37%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$0.87 -0.01 (-0.75%)
As of 08/21/2025 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. More about IceCure Medical

Market Capitalization
$50.20 million
P/E Ratio
-5.47
Consensus Rating
Buy
Consensus Price Target
$2.39 (+172.4% Upside)
Volume
182,583 shares
Average Volume
2.80 million shares
Gain Therapeutics stock logo

22. Gain Therapeutics NASDAQ:GANX

$1.81 +0.08 (+4.62%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$1.82 +0.01 (+0.83%)
As of 08/21/2025 06:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. More about Gain Therapeutics

Market Capitalization
$62.19 million
P/E Ratio
-2.87
Consensus Rating
Buy
Consensus Price Target
$7.80 (+330.9% Upside)
Volume
137,733 shares
Average Volume
331,878 shares
Ceragon Networks stock logo

23. Ceragon Networks NASDAQ:CRNT

$1.90 +0.02 (+1.06%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$1.90 0.00 (0.00%)
As of 08/21/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ceragon Networks Ltd., together with its subsidiaries, provides wireless transport solutions for cellular operators and other wireless service providers in North America, Europe, Africa, the Asia Pacific, the Middle East, India, and Latin America. More about Ceragon Networks

Market Capitalization
$167.19 million
P/E Ratio
11.88
Consensus Rating
Buy
Consensus Price Target
$5.30 (+178.9% Upside)
Volume
363,695 shares
Average Volume
1.01 million shares
TScan Therapeutics stock logo

24. TScan Therapeutics NASDAQ:TCRX

$1.74 +0.04 (+2.35%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$1.75 +0.01 (+0.57%)
As of 08/21/2025 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TScan Therapeutics, Inc, a clinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. More about TScan Therapeutics

Market Capitalization
$96.20 million
P/E Ratio
-1.60
Consensus Rating
Buy
Consensus Price Target
$7.80 (+348.3% Upside)
Volume
240,730 shares
Average Volume
254,189 shares
Tenaya Therapeutics stock logo

25. Tenaya Therapeutics NASDAQ:TNYA

$1.16 -0.08 (-6.45%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$1.18 +0.02 (+1.29%)
As of 08/21/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya Therapeutics

Market Capitalization
$202.09 million
P/E Ratio
-1.21
Consensus Rating
Buy
Consensus Price Target
$6.25 (+438.8% Upside)
Volume
2.55 million shares
Average Volume
3.96 million shares